Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity.
暂无分享,去创建一个
Jo Klaveness | J. Klaveness | S. Fossheim | G. Stensrud | Sigrid L Fossheim | Christian Gløgård | Gry Stensrud | Ragnar Hovland | Ragnar Hovland | C. Gløgård
[1] Kazuo Maruyama,et al. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.
[2] R. Muller,et al. Paramagnetic liposomes as magnetic resonance imaging contrast agents. Assessment of contrast efficacy in various liver models. , 1998, Investigative radiology.
[3] R. Lauffer,et al. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.
[4] Tilcock. Delivery of contrast agents for magnetic resonance imaging, computed tomography, nuclear medicine and ultrasound. , 1999, Advanced drug delivery reviews.
[5] K. Hubner,et al. Gadolinium‐labeled liposomes containing various amphiphilic Gd‐DTPA derivatives: Targeted MRI contrast enhancement agents for the liver , 1991, Magnetic resonance in medicine.
[6] S. H. Koenig,et al. The design of liposomal paramagnetic mr agents: effect of vesicle size upon the relaxivity of surface‐incorporated lipophilic chelates , 1992, Magnetic resonance in medicine.
[7] Babich,et al. Long-circulating gadolinium-loaded liposomes: potential use for magnetic resonance imaging of the blood pool. , 2000, Colloids and surfaces. B, Biointerfaces.
[8] J. Klaveness,et al. Synthesis and physicochemical characterisation of new amphiphilic gadolinium DO3A complexes as contrast agents for MRI , 2000 .
[9] M. Botta. Second Coordination Sphere Water Molecules and Relaxivity of Gadolinium(III) Complexes: Implications for MRI Contrast Agents , 2000 .
[10] J. M. Garrison,et al. pH dependence of relaxivities and hydration numbers of gadolinium(III) complexes of macrocyclic amino carboxylates , 1990 .
[11] V. Torchilin,et al. Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties. , 1995, Magnetic resonance imaging.
[12] R. Schwendener. Liposomes as carriers for paramagnetic gadolinium chelates as organ specific contrast agents for magnetic resonance imaging (mri) , 1994 .
[13] A. Seelig,et al. High Relaxivity for Monomeric Gd(DOTA)‐Based MRI Contrast Agents, Thanks to Micellar Self‐Organization , 1999 .
[14] E. Terreno,et al. NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[15] R. Gatenby,et al. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging. , 1989, Radiology.
[16] J. Teissié,et al. Ionization of phospholipids and phospholipid-supported interfacial lateral diffusion of protons in membrane model systems. , 1990, Biochimica et biophysica acta.
[17] Palmisano,et al. NOVEL PARAMAGNETIC MACROMOLECULAR COMPLEXES DERIVED FROM THE LINKAGE OF A MACROCYCLIC Gd(III) COMPLEX TO POLYAMINO ACIDS THROUGH A SQUARIC ACID MOIETY , 1999, Bioconjugate chemistry.
[18] Okuhata,et al. Delivery of diagnostic agents for magnetic resonance imaging. , 1999, Advanced drug delivery reviews.
[19] S. Marčelja,et al. Physical principles of membrane organization , 1980, Quarterly Reviews of Biophysics.